Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZL23
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,394
Award facts
- Contract value 100% obligated
- $28,393.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,393.50 to DMS Pharmaceutical Group Inc. for the supply of Nucala 100 mg/ml auto-injector units. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with an ultimate completion date of September 23, 2025. This delivery order was issued without a set-aside designation, allowing the contractor to compete on an unrestricted basis in the federal pharmaceutical supply market.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at approximately $500 million and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Through this vehicle, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering specialized medications and auto-injector products to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FZL23?
SPE2DB25FZL23 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FZL23 worth?
The government has obligated $28,394 on SPE2DB25FZL23.
Is contract SPE2DB25FZL23 an order under another contract?
Yes. SPE2DB25FZL23 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL23 competed?
The extent of competition for SPE2DB25FZL23 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award